Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis.
INTRODUCTION:Progressive brain atrophy, development of T1-hypointense areas, and T2-fluid-attenuated inversion recovery (FLAIR)-hyperintense lesion formation in multiple sclerosis (MS) are popular volumetric data that are often utilized as clinical outcomes. However, the exact clinical interpretatio...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2020-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0231225 |
| _version_ | 1818582349829373952 |
|---|---|
| author | Tetsuya Akaishi Toshiyuki Takahashi Kazuo Fujihara Tatsuro Misu Shunji Mugikura Michiaki Abe Tadashi Ishii Masashi Aoki Ichiro Nakashima |
| author_facet | Tetsuya Akaishi Toshiyuki Takahashi Kazuo Fujihara Tatsuro Misu Shunji Mugikura Michiaki Abe Tadashi Ishii Masashi Aoki Ichiro Nakashima |
| author_sort | Tetsuya Akaishi |
| collection | DOAJ |
| description | INTRODUCTION:Progressive brain atrophy, development of T1-hypointense areas, and T2-fluid-attenuated inversion recovery (FLAIR)-hyperintense lesion formation in multiple sclerosis (MS) are popular volumetric data that are often utilized as clinical outcomes. However, the exact clinical interpretation of these volumetric data has not yet been fully established. METHODS:We enrolled 42 consecutive patients with MS who fulfilled the revised McDonald criteria of 2010. They were followed-up for more than 3 years from onset, and cross-sectional brain volumetry was performed. Patients with no brain lesions were excluded in advance from this study. For the brain volumetric data, we evaluated several parameters including age-adjusted gray-matter volume atrophy, age-adjusted white-matter volume atrophy, and T2-FLAIR lesion volume. The numbers of T1-hypointense and T2-FLAIR-hyperintense areas were also measured along the same timeline. The clinical data pertaining to disease duration, expanded disability status scale (EDSS), and MS severity score (MSSS) at the timing of volumetry were collected. RESULTS:Among the 42 patients with MS and brain lesions, the number of T1-hypointensity (rho = 0.51, p<0.001), gray-matter atrophy (rho = 0.40, p<0.01) and white-matter atrophy (rho = 0.49, p<0.001) correlated with the EDSS. T1-hypointensity count divided by FLAIR lesion volume correlated with the MSSS (rho = 0.60, p<0.001). Meanwhile, counts or volumes of FLAIR-hyperintense lesions were associated only with the times of past relapses, and did not correlate with present neurological disability level or ongoing disease activity. These findings were consistent regardless of the presence of spinal cord lesions. CONCLUSION:Numbers of T1-hypointensities and brain atrophy equally indicated the current neurological disability in MS. The number of T1-hypointensities divided by FLAIR lesion volume represented the clinical severity. The size or number of FLAIR lesions reflected earlier relapses but was not a good indicator of neurological disability or clinical severity. |
| first_indexed | 2024-12-16T07:47:59Z |
| format | Article |
| id | doaj.art-b975a37da166461d9914fa4c164d1ca4 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-16T07:47:59Z |
| publishDate | 2020-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-b975a37da166461d9914fa4c164d1ca42022-12-21T22:38:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01154e023122510.1371/journal.pone.0231225Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis.Tetsuya AkaishiToshiyuki TakahashiKazuo FujiharaTatsuro MisuShunji MugikuraMichiaki AbeTadashi IshiiMasashi AokiIchiro NakashimaINTRODUCTION:Progressive brain atrophy, development of T1-hypointense areas, and T2-fluid-attenuated inversion recovery (FLAIR)-hyperintense lesion formation in multiple sclerosis (MS) are popular volumetric data that are often utilized as clinical outcomes. However, the exact clinical interpretation of these volumetric data has not yet been fully established. METHODS:We enrolled 42 consecutive patients with MS who fulfilled the revised McDonald criteria of 2010. They were followed-up for more than 3 years from onset, and cross-sectional brain volumetry was performed. Patients with no brain lesions were excluded in advance from this study. For the brain volumetric data, we evaluated several parameters including age-adjusted gray-matter volume atrophy, age-adjusted white-matter volume atrophy, and T2-FLAIR lesion volume. The numbers of T1-hypointense and T2-FLAIR-hyperintense areas were also measured along the same timeline. The clinical data pertaining to disease duration, expanded disability status scale (EDSS), and MS severity score (MSSS) at the timing of volumetry were collected. RESULTS:Among the 42 patients with MS and brain lesions, the number of T1-hypointensity (rho = 0.51, p<0.001), gray-matter atrophy (rho = 0.40, p<0.01) and white-matter atrophy (rho = 0.49, p<0.001) correlated with the EDSS. T1-hypointensity count divided by FLAIR lesion volume correlated with the MSSS (rho = 0.60, p<0.001). Meanwhile, counts or volumes of FLAIR-hyperintense lesions were associated only with the times of past relapses, and did not correlate with present neurological disability level or ongoing disease activity. These findings were consistent regardless of the presence of spinal cord lesions. CONCLUSION:Numbers of T1-hypointensities and brain atrophy equally indicated the current neurological disability in MS. The number of T1-hypointensities divided by FLAIR lesion volume represented the clinical severity. The size or number of FLAIR lesions reflected earlier relapses but was not a good indicator of neurological disability or clinical severity.https://doi.org/10.1371/journal.pone.0231225 |
| spellingShingle | Tetsuya Akaishi Toshiyuki Takahashi Kazuo Fujihara Tatsuro Misu Shunji Mugikura Michiaki Abe Tadashi Ishii Masashi Aoki Ichiro Nakashima Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis. PLoS ONE |
| title | Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis. |
| title_full | Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis. |
| title_fullStr | Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis. |
| title_full_unstemmed | Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis. |
| title_short | Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis. |
| title_sort | number of mri t1 hypointensity corrected by t2 flair lesion volume indicates clinical severity in patients with multiple sclerosis |
| url | https://doi.org/10.1371/journal.pone.0231225 |
| work_keys_str_mv | AT tetsuyaakaishi numberofmrit1hypointensitycorrectedbyt2flairlesionvolumeindicatesclinicalseverityinpatientswithmultiplesclerosis AT toshiyukitakahashi numberofmrit1hypointensitycorrectedbyt2flairlesionvolumeindicatesclinicalseverityinpatientswithmultiplesclerosis AT kazuofujihara numberofmrit1hypointensitycorrectedbyt2flairlesionvolumeindicatesclinicalseverityinpatientswithmultiplesclerosis AT tatsuromisu numberofmrit1hypointensitycorrectedbyt2flairlesionvolumeindicatesclinicalseverityinpatientswithmultiplesclerosis AT shunjimugikura numberofmrit1hypointensitycorrectedbyt2flairlesionvolumeindicatesclinicalseverityinpatientswithmultiplesclerosis AT michiakiabe numberofmrit1hypointensitycorrectedbyt2flairlesionvolumeindicatesclinicalseverityinpatientswithmultiplesclerosis AT tadashiishii numberofmrit1hypointensitycorrectedbyt2flairlesionvolumeindicatesclinicalseverityinpatientswithmultiplesclerosis AT masashiaoki numberofmrit1hypointensitycorrectedbyt2flairlesionvolumeindicatesclinicalseverityinpatientswithmultiplesclerosis AT ichironakashima numberofmrit1hypointensitycorrectedbyt2flairlesionvolumeindicatesclinicalseverityinpatientswithmultiplesclerosis |